Comparison - IMCR - NASDAQ

Weiss Ratings	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	E
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Weak
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.85

Price History	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-4.78%
30-Day Total Return	-8.97%
60-Day Total Return	-3.49%
90-Day Total Return	-8.97%
Year to Date Total Return	-4.85%
1-Year Total Return	-53.09%
2-Year Total Return	-44.40%
3-Year Total Return	0.80%
5-Year Total Return	--
52-Week High % Change	-54.48%
52-Week Low % Change	10.48%

Price	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$66.00
52-Week Low Price	$27.19
52-Week Low Price (Date)	Mar 11, 2025
52-Week High Price (Date)	Apr 01, 2024

Valuation	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	1.50B
Enterprise Value	1.12B
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-1.03
Earnings Per Share Growth	-9.38%
Price/Earnings To Growth	--
Price/Sales (TTM)	4.85
Price/Book (Q)	4.17
Enterprise Value/Revenue (TTM)	3.60
Price	$28.38
Enterprise Value/EBITDA (TTM)	-23.16
Enterprise Value/EBIT	-21.30
Market Cap Category	Small Cap

Dividends and Shares	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	50.05M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	44 12 3543 8600
Address	--
Website	www.immunocore.com
Country	United Kingdom
Year Founded	1999

Profitability	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-16.89%
Profit Margin	-16.46%

Management Effectiveness	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-4.08%
Return on Equity	--

Income Statement	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	310.20M
Total Revenue (TTM)	310.20M
Revenue Per Share	$6.20
Gross Profit (TTM)	295.55M
EBITDA (TTM)	-48.21M
EBIT (TTM)	-52.41M
Net Income (TTM)	-51.09M
Net Income Avl. to Common (TTM)	-51.09M
Total Revenue Growth (Q YOY)	19.80%
Earnings Growth (Q YOY)	-20.48%
EPS Diluted (TTM)	-1.03
EPS Diluted Growth (Q YOY)	-19.08%

Balance Sheet	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	820.38M
Cash Per Share (Q)	$16.39
Total Current Assets (Q)	929.86M
Total Preferred Equity (Q)	--
Total Equity (Q)	360.72M
Current Ratio (Q)	4.382
Book Value Per Share (Q)	$7.21
Total Assets (Q)	1.01B
Total Current Liabilities (Q)	212.18M
Total Debt (Q)	432.72M
Total Liabilities (Q)	648.79M
Total Common Equity (Q)	360.72M

Cash Flow	IMCR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-355.13M
Cash from Financing (TTM)	343.88M
Net Change in Cash (TTM)	13.11M
Levered Free Cash Flow (TTM)	38.39M
Cash from Operations (TTM)	26.06M